Robert N Fried
CIK 1417952 · Chief Executive Officer · last filed 2026-04-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.98M
Companies
5
Total Filings
44
Lifetime Open-Market Net
$423.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NAGE | Chief Executive Officer | 1,153,982 | $3.45 | $3.98M | $0 | 3 | 2026-04-27 |
| Niagen Bioscience, Inc. (CDXC) Delisted | Chief Executive Officer | 1,067,315 | $7.87 | $8.40M | $423.7K | 28 | 2025-02-27 |
| Fluent, Inc. (IDI) Delisted | Director | 318,671 | — | — | $0 | 5 | 2016-06-03 |
| Fluent, Inc. (IDI.WS) Delisted | President & CEO | — | — | — | $0 | 2 | 2010-01-13 |
| Ideation Acquisition Corp. (IDI.U) Delisted | President & CEO | 620,500 | — | — | $0 | 1 | 2007-11-28 |
Recent Filings · Page 3 of 5
44 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-02-22 | Niagen Bioscience, Inc. (CDXC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-11-09 | Niagen Bioscience, Inc. (CDXC) Delisted | Grant (A) | +166,667 | $0 | EDGAR |
| 2018-06-26 | Niagen Bioscience, Inc. (CDXC) Delisted | Grant (A) | +166,667 | $0 | EDGAR |
| 2018-05-16 | Niagen Bioscience, Inc. (CDXC) Delisted | Buy (P) | +10,000 | $36.3K | EDGAR |
| 2018-05-15 | Niagen Bioscience, Inc. (CDXC) Delisted | Grant (A) | +10,000 | $36.3K | EDGAR |
| 2018-01-23 | Niagen Bioscience, Inc. (CDXC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-12-21 | Niagen Bioscience, Inc. (CDXC) Delisted | Grant (A) | +333,333 | $0 | EDGAR |
| 2017-08-16 | Niagen Bioscience, Inc. (CDXC) Delisted | Buy (P) | +10,000 | $31.5K | EDGAR |
| 2017-04-17 | — | Grant (A) | +15,000 | $0 | |
| 2017-03-14 | Niagen Bioscience, Inc. (CDXC) Delisted | Grant (A) | +506,262 | $923.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.